PDCD1 and cancer: Recently, a complete cancer eradication was achieved with a vaccine based on a neoantigen-painted serum exosome in combination with programmed cell death protein 1 (PD-1) antibodies in mice with colon cancer, opening a new scenario involving the use of exosomes derived from patients and enhanced with directional antibodies for highly efficient personalized therapy [276].